No products in the cart.
Telostrand Innovations is proud to introduce the next evolution of non-invasive, at-home diagnostics: Telostrand Viral.
Built on our patent-pending methodologies (HPV via Urine and Pathogens via Urine), this platform redefines how viral testing is performed, making it more accessible, discreet, and patient-centered.
Telostrand Viral utilizes proprietary reagents developed in-house and validated through rigorous internal processes, including regulatory compliance standards and proficiency testing. By combining these reagents with advanced nucleic acid amplification techniques, we deliver reliable, high-quality results from a single, non-invasive urine sample.
But this is no longer just a viral testing platform.
Telostrand Viral is now fully integrated into Telostrand OneCup™ — our unified testing system that enables comprehensive screening for all 14 major STD / STI’s using just one urine sample.
Telostrand OneCup™ screens for:
- Human Papillomavirus (HPV 16, 18, 48)
- Human Immunodeficiency Virus Type 1 (HIV-1)
- Human Immunodeficiency Virus Type 2 (HIV-2)
- Hepatitis C Virus (HCV)
- Chlamydia trachomatis (CT)
- Neisseria gonorrhoeae (NG)
- Trichomonas vaginalis (TV)
- Mycoplasma genitalium (MG)
- Herpes Simplex Virus Type 1 (HSV-1)
- Herpes Simplex Virus Type 2 (HSV-2)
- Treponema pallidum (Syphilis)
This integration represents a fundamental shift in how diagnostic care is delivered: streamlined, scalable, and built for real life.
At its core, Telostrand is about improving lives through better access to care. Peace of mind should not come with barriers, delays, or discomfort. With one simple collection, Telostrand OneCup™ delivers clarity, confidence, and control back to the patient.
For more information about Telostrand Viral, our patent portfolio, or our laboratory services, please contact us at Cs@telostrand.com.